The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 16, 2025

Filed:

Apr. 04, 2024
Applicant:

Sanofi, Paris, FR;

Inventor:

Paolo Mangiagalli, Paris, FR;

Assignee:

SANOFI, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B29C 43/18 (2006.01); A61M 5/142 (2006.01); A61M 5/20 (2006.01); A61M 5/315 (2006.01); A61M 5/32 (2006.01); B29C 35/08 (2006.01); B29C 43/30 (2006.01); B29C 43/34 (2006.01); B29K 23/00 (2006.01); B29K 83/00 (2006.01);
U.S. Cl.
CPC ...
B29C 43/18 (2013.01); A61M 5/142 (2013.01); A61M 5/20 (2013.01); A61M 5/31511 (2013.01); A61M 5/32 (2013.01); B29C 35/0805 (2013.01); B29C 43/305 (2013.01); B29C 43/34 (2013.01); A61M 2205/0216 (2013.01); A61M 2205/0238 (2013.01); A61M 2207/00 (2013.01); A61M 2207/10 (2013.01); B29C 2035/0827 (2013.01); B29C 2043/182 (2013.01); B29K 2023/22 (2013.01); B29K 2083/005 (2013.01);
Abstract

A technique of manufacturing an elastomeric container closure or plunger with embedded functional components to avoid thermal damage to the components is described. The technique includes molding a drug-contacting part from a first material at a first temperature and for a first length of time defining a first thermal exposure; after molding the drug-contacting part, inserting ancillary components into the drug-contacting part, where the ancillary components have an operational thermal budget less than the first thermal exposure; and overmolding the drug-contracting part and the ancillary components with a second material at a second temperature for a second length of time to form a non-drug-contacting part that mechanically connects the non-drug-contacting part and the drug-contacting part to form the elastomeric container closure and seals the ancillary components inside the elastomeric container closure. The overmolding defines a thermal exposure less than the operational thermal budget of the ancillary components.


Find Patent Forward Citations

Loading…